188 related articles for article (PubMed ID: 24259486)
1. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.
Qi YJ; Ward DG; Pang C; Wang QM; Wei W; Ma J; Zhang J; Lou Q; Shimwell NJ; Martin A; Wong N; Chao WX; Wang M; Ma YF; Johnson PJ
Proteomics; 2014 Feb; 14(2-3):186-95. PubMed ID: 24259486
[TBL] [Abstract][Full Text] [Related]
2. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
3. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma.
Na K; Lee EY; Lee HJ; Kim KY; Lee H; Jeong SK; Jeong AS; Cho SY; Kim SA; Song SY; Kim KS; Cho SW; Kim H; Paik YK
Proteomics; 2009 Aug; 9(16):3989-99. PubMed ID: 19658107
[TBL] [Abstract][Full Text] [Related]
4. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
[TBL] [Abstract][Full Text] [Related]
5. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
6. Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (Sun S; Poon RT; Lee NP; Yeung C; Chan KL; Ng IO; Day PJ; Luk JM
J Proteome Res; 2010 Apr; 9(4):1923-30. PubMed ID: 20121168
[TBL] [Abstract][Full Text] [Related]
7. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma.
Huang C; Wang Y; Liu S; Ding G; Liu W; Zhou J; Kuang M; Ji Y; Kondo T; Fan J
J Proteome Res; 2013 Apr; 12(4):1838-46. PubMed ID: 23442176
[TBL] [Abstract][Full Text] [Related]
10. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
11. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
12. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
[TBL] [Abstract][Full Text] [Related]
14. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
15. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
[TBL] [Abstract][Full Text] [Related]
16. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
17. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE.
Ferrín G; Ranchal I; Llamoza C; Rodríguez-Perálvarez ML; Romero-Ruiz A; Aguilar-Melero P; López-Cillero P; Briceño J; Muntané J; Montero-Álvarez JL; De la Mata M
Liver Int; 2014 Mar; 34(3):438-46. PubMed ID: 23944848
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma.
Cheng ZX; Huang XH; Wang Q; Chen JS; Zhang LJ; Chen XL
J Surg Oncol; 2012 Jan; 105(1):71-80. PubMed ID: 21815147
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
